4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-046082
Chief Financial Officer sold 20,000 shares at an average $38.68 ($773,619)
- Chief Financial Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Chad M · Chief Financial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-06 | Exercise or conversion : show line 1 in the form | +10,000 | $6.55 | $65,500 | 31,604 | D |
| 2021-07-06 | Sale : show line 2 in the form | −10,000 | $38.83 | $388,300 | 21,604 | D |
| 2021-07-07 | Exercise or conversion : show line 3 in the form | +10,000 | $6.55 | $65,500 | 31,604 | D |
| 2021-07-07 | Sale : show line 4 in the form | −6,486 | $38.17 | $247,571 | 25,118 | D |
| 2021-07-07 | Sale : show line 5 in the form | −3,514 | $39.20 | $137,749 | 21,604 | D |
| Open-market sales · 20,000 sh · avg $38.68 · $773,619 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-07-06 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −10,000 | 100,000 | D |
| 2021-07-07 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −10,000 | 90,000 | D |
Loading xslF345X03/doc4.xml…